Suboxone vs. Vivitrol vs. Methadone: Which Medication Is Right for You?
The honest, unsponsored comparison of every FDA-approved medication for opioid use disorder. What the evidence shows — and what some programs won't tell you.
MAT — The Evidence
MAT is the gold standard for OUD. Studies show 50% lower overdose mortality, better retention, lower HIV rates, reduced criminal activity. Yet some programs refuse MAT — often for ideological reasons dressed up as clinical rationale.
Buprenorphine (Suboxone)
Partial opioid agonist — prevents withdrawal and cravings with a ceiling effect preventing the high
Can begin in moderate withdrawal, available via telehealth
Indefinite duration — tapering should be patient-driven, not program-driven
Best for: Most people with OUD — the most accessible, flexible MAT option
Naltrexone (Vivitrol)
Monthly injection blocking all opioid receptors completely
Requires 7-10 days full opioid abstinence before first dose — precipitated withdrawal risk
Best for: Highly motivated individuals, those transitioning from jail/prison
Methadone
Full opioid agonist dispensed daily at licensed OTP clinics
Daily clinic visits initially; take-homes earned through compliance
Best for: High-severity OUD, people who have failed buprenorphine
The "Medication-Free" Recovery Myth
Programs that prohibit MAT and frame it as "not real recovery" are not supported by clinical evidence. If a program requires you to stop MAT upon admission without a medical rationale, that is a significant red flag.